APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hereditary Angioedema Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Hereditary Angioedema Drug Market Analysis and Forecast 2026-2032

Report ID 173998300220 December 2025198 pages

Choose your research edition.

Industry ResearchHereditary Angioedema Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Hereditary Angioedema Drug Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Hereditary Angioedema Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hereditary Angioedema Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Hereditary Angioedema Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Hereditary Angioedema Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Hereditary Angioedema Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Hereditary Angioedema Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Hereditary Angioedema Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Hereditary Angioedema Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Hereditary Angioedema Drug include Takeda, Pharming Group NV, Ionis Pharmaceuticals, Inc., IBio Inc., CSL Limited and BioCryst Pharmaceuticals, Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Hereditary Angioedema Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Hereditary Angioedema Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Hereditary Angioedema Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hereditary Angioedema Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Hereditary Angioedema Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Hereditary Angioedema Drug sales, projected growth trends, production technology, application and end-user industry.

Hereditary Angioedema Drug Segment by Company

Takeda

Pharming Group NV

Ionis Pharmaceuticals, Inc.

IBio Inc.

CSL Limited

BioCryst Pharmaceuticals, Inc.

Hereditary Angioedema Drug Segment by Type

C1 Esterase Inhibitor

Kallikrein Inhibitor

Selective Bradykinin B2 Receptor Antagonist

Hereditary Angioedema Drug Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Hereditary Angioedema Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hereditary Angioedema Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hereditary Angioedema Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hereditary Angioedema Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Hereditary Angioedema Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Hereditary Angioedema Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hereditary Angioedema Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hereditary Angioedema Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. C1 Esterase Inhibitor Major Manufacturers Table 3. Kallikrein Inhibitor Major Manufacturers Table 4. Selective Bradykinin B2 Receptor Antagonist Major Manufacturers Table 5. Global Hereditary Angioedema Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Pharmacies Major Manufacturers Table 7. Online Pharmacies Major Manufacturers Table 8. Retail Pharmacies Major Manufacturers Table 9. Hereditary Angioedema Drug Industry Trends Table 10. Hereditary Angioedema Drug Industry Drivers Table 11. Hereditary Angioedema Drug Industry Opportunities and Challenges Table 12. Hereditary Angioedema Drug Industry Restraints Table 13. Global Hereditary Angioedema Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Hereditary Angioedema Drug Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Hereditary Angioedema Drug Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Hereditary Angioedema Drug Revenue Market Share by Region (2021-2026) Table 17. Global Hereditary Angioedema Drug Revenue Market Share by Region (2027-2032) Table 18. Global Hereditary Angioedema Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 19. Global Hereditary Angioedema Drug Sales by Region (2021-2026) & (W Units) Table 20. Global Hereditary Angioedema Drug Sales by Region (2027-2032) & (W Units) Table 21. Global Hereditary Angioedema Drug Sales Market Share by Region (2021-2026) Table 22. Global Hereditary Angioedema Drug Sales Market Share by Region (2027-2032) Table 23. Global Hereditary Angioedema Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Hereditary Angioedema Drug Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Hereditary Angioedema Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Hereditary Angioedema Drug Sales Market Share by Manufacturers (2021-2026) Table 27. Global Hereditary Angioedema Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Hereditary Angioedema Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Hereditary Angioedema Drug Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Hereditary Angioedema Drug Manufacturers, Product Type & Application Table 31. Global Hereditary Angioedema Drug Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Hereditary Angioedema Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Hereditary Angioedema Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Hereditary Angioedema Drug Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Hereditary Angioedema Drug Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Hereditary Angioedema Drug Revenue Market Share by Type (2021-2026) Table 38. Global Hereditary Angioedema Drug Revenue Market Share by Type (2027-2032) Table 39. Global Hereditary Angioedema Drug Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 40. Global Hereditary Angioedema Drug Sales by Type (2021-2026) & (W Units) Table 41. Global Hereditary Angioedema Drug Sales by Type (2027-2032) & (W Units) Table 42. Global Hereditary Angioedema Drug Sales Market Share by Type (2021-2026) Table 43. Global Hereditary Angioedema Drug Sales Market Share by Type (2027-2032) Table 44. Global Hereditary Angioedema Drug Price by Type (2021-2026) & (US$/Unit) Table 45. Global Hereditary Angioedema Drug Price by Type (2027-2032) & (US$/Unit) Table 46. Global Hereditary Angioedema Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Hereditary Angioedema Drug Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Hereditary Angioedema Drug Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Hereditary Angioedema Drug Revenue Market Share by Application (2021-2026) Table 50. Global Hereditary Angioedema Drug Revenue Market Share by Application (2027-2032) Table 51. Global Hereditary Angioedema Drug Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 52. Global Hereditary Angioedema Drug Sales by Application (2021-2026) & (W Units) Table 53. Global Hereditary Angioedema Drug Sales by Application (2027-2032) & (W Units) Table 54. Global Hereditary Angioedema Drug Sales Market Share by Application (2021-2026) Table 55. Global Hereditary Angioedema Drug Sales Market Share by Application (2027-2032) Table 56. Global Hereditary Angioedema Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Hereditary Angioedema Drug Price by Application (2027-2032) & (US$/Unit) Table 58. Takeda Company Information Table 59. Takeda Business Overview Table 60. Takeda Hereditary Angioedema Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Takeda Hereditary Angioedema Drug Product Portfolio Table 62. Takeda Recent Development Table 63. Pharming Group NV Company Information Table 64. Pharming Group NV Business Overview Table 65. Pharming Group NV Hereditary Angioedema Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Pharming Group NV Hereditary Angioedema Drug Product Portfolio Table 67. Pharming Group NV Recent Development Table 68. Ionis Pharmaceuticals, Inc. Company Information Table 69. Ionis Pharmaceuticals, Inc. Business Overview Table 70. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Portfolio Table 72. Ionis Pharmaceuticals, Inc. Recent Development Table 73. IBio Inc. Company Information Table 74. IBio Inc. Business Overview Table 75. IBio Inc. Hereditary Angioedema Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. IBio Inc. Hereditary Angioedema Drug Product Portfolio Table 77. IBio Inc. Recent Development Table 78. CSL Limited Company Information Table 79. CSL Limited Business Overview Table 80. CSL Limited Hereditary Angioedema Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. CSL Limited Hereditary Angioedema Drug Product Portfolio Table 82. CSL Limited Recent Development Table 83. BioCryst Pharmaceuticals, Inc. Company Information Table 84. BioCryst Pharmaceuticals, Inc. Business Overview Table 85. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Portfolio Table 87. BioCryst Pharmaceuticals, Inc. Recent Development Table 88. North America Hereditary Angioedema Drug Revenue by Type (2021-2026) & (US$ Million) Table 89. North America Hereditary Angioedema Drug Revenue by Type (2027-2032) & (US$ Million) Table 90. North America Hereditary Angioedema Drug Sales by Type (2021-2026) & (W Units) Table 91. North America Hereditary Angioedema Drug Sales by Type (2027-2032) & (W Units) Table 92. North America Hereditary Angioedema Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 93. North America Hereditary Angioedema Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 94. North America Hereditary Angioedema Drug Revenue by Application (2021-2026) & (US$ Million) Table 95. North America Hereditary Angioedema Drug Revenue by Application (2027-2032) & (US$ Million) Table 96. North America Hereditary Angioedema Drug Sales by Application (2021-2026) & (W Units) Table 97. North America Hereditary Angioedema Drug Sales by Application (2027-2032) & (W Units) Table 98. North America Hereditary Angioedema Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 99. North America Hereditary Angioedema Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 100. North America Hereditary Angioedema Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Hereditary Angioedema Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 102. North America Hereditary Angioedema Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 103. North America Hereditary Angioedema Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 104. North America Hereditary Angioedema Drug Sales by Country (2021-2026) & (W Units) Table 105. North America Hereditary Angioedema Drug Sales by Country (2027-2032) & (W Units) Table 106. North America Hereditary Angioedema Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 107. North America Hereditary Angioedema Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 108. United States Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 109. Canada Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 110. Europe Hereditary Angioedema Drug Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Hereditary Angioedema Drug Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Hereditary Angioedema Drug Sales by Type (2021-2026) & (W Units) Table 113. Europe Hereditary Angioedema Drug Sales by Type (2027-2032) & (W Units) Table 114. Europe Hereditary Angioedema Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 115. Europe Hereditary Angioedema Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 116. Europe Hereditary Angioedema Drug Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Hereditary Angioedema Drug Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Hereditary Angioedema Drug Sales by Application (2021-2026) & (W Units) Table 119. Europe Hereditary Angioedema Drug Sales by Application (2027-2032) & (W Units) Table 120. Europe Hereditary Angioedema Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 121. Europe Hereditary Angioedema Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 122. Europe Hereditary Angioedema Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Hereditary Angioedema Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. Europe Hereditary Angioedema Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. Europe Hereditary Angioedema Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 126. Europe Hereditary Angioedema Drug Sales by Country (2021-2026) & (W Units) Table 127. Europe Hereditary Angioedema Drug Sales by Country (2027-2032) & (W Units) Table 128. Europe Hereditary Angioedema Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 129. Europe Hereditary Angioedema Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 130. Germany Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 131. France Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 132. U.K. Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 133. Italy Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 134. Netherlands Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 135. China Hereditary Angioedema Drug Revenue by Type (2021-2026) & (US$ Million) Table 136. China Hereditary Angioedema Drug Revenue by Type (2027-2032) & (US$ Million) Table 137. China Hereditary Angioedema Drug Sales by Type (2021-2026) & (W Units) Table 138. China Hereditary Angioedema Drug Sales by Type (2027-2032) & (W Units) Table 139. China Hereditary Angioedema Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 140. China Hereditary Angioedema Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 141. China Hereditary Angioedema Drug Revenue by Application (2021-2026) & (US$ Million) Table 142. China Hereditary Angioedema Drug Revenue by Application (2027-2032) & (US$ Million) Table 143. China Hereditary Angioedema Drug Sales by Application (2021-2026) & (W Units) Table 144. China Hereditary Angioedema Drug Sales by Application (2027-2032) & (W Units) Table 145. China Hereditary Angioedema Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 146. China Hereditary Angioedema Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Asia Hereditary Angioedema Drug Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Hereditary Angioedema Drug Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Hereditary Angioedema Drug Sales by Type (2021-2026) & (W Units) Table 150. Asia Hereditary Angioedema Drug Sales by Type (2027-2032) & (W Units) Table 151. Asia Hereditary Angioedema Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 152. Asia Hereditary Angioedema Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 153. Asia Hereditary Angioedema Drug Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Hereditary Angioedema Drug Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Hereditary Angioedema Drug Sales by Application (2021-2026) & (W Units) Table 156. Asia Hereditary Angioedema Drug Sales by Application (2027-2032) & (W Units) Table 157. Asia Hereditary Angioedema Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 158. Asia Hereditary Angioedema Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 159. Asia Hereditary Angioedema Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Hereditary Angioedema Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia Hereditary Angioedema Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia Hereditary Angioedema Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 163. Asia Hereditary Angioedema Drug Sales by Country (2021-2026) & (W Units) Table 164. Asia Hereditary Angioedema Drug Sales by Country (2027-2032) & (W Units) Table 165. Asia Hereditary Angioedema Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 166. Asia Hereditary Angioedema Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 167. Japan Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 168. South Korea Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 169. India Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 170. Australia Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 171. China Taiwan Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 173. SAMEA Hereditary Angioedema Drug Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Hereditary Angioedema Drug Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Hereditary Angioedema Drug Sales by Type (2021-2026) & (W Units) Table 176. SAMEA Hereditary Angioedema Drug Sales by Type (2027-2032) & (W Units) Table 177. SAMEA Hereditary Angioedema Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 178. SAMEA Hereditary Angioedema Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 179. SAMEA Hereditary Angioedema Drug Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA Hereditary Angioedema Drug Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA Hereditary Angioedema Drug Sales by Application (2021-2026) & (W Units) Table 182. SAMEA Hereditary Angioedema Drug Sales by Application (2027-2032) & (W Units) Table 183. SAMEA Hereditary Angioedema Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 184. SAMEA Hereditary Angioedema Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 185. SAMEA Hereditary Angioedema Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA Hereditary Angioedema Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA Hereditary Angioedema Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA Hereditary Angioedema Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 189. SAMEA Hereditary Angioedema Drug Sales by Country (2021-2026) & (W Units) Table 190. SAMEA Hereditary Angioedema Drug Sales by Country (2027-2032) & (W Units) Table 191. SAMEA Hereditary Angioedema Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 192. SAMEA Hereditary Angioedema Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 193. Brazil Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 194. Argentina Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 195. Chile Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 196. Colombia Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 197. Peru Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 199. Israel Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 200. UAE Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 201. Turkey Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 202. Iran Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 203. Egypt Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Hereditary Angioedema Drug Distributors List Table 207. Hereditary Angioedema Drug Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Hereditary Angioedema Drug Image Figure 2. Global Hereditary Angioedema Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hereditary Angioedema Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. C1 Esterase Inhibitor Image Figure 5. Kallikrein Inhibitor Image Figure 6. Selective Bradykinin B2 Receptor Antagonist Image Figure 7. Global Hereditary Angioedema Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Hereditary Angioedema Drug Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Pharmacies Image Figure 10. Online Pharmacies Image Figure 11. Retail Pharmacies Image Figure 12. Global Hereditary Angioedema Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Hereditary Angioedema Drug Revenue (2021-2032) & (US$ Million) Figure 14. Global Hereditary Angioedema Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Hereditary Angioedema Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Hereditary Angioedema Drug Revenue Market Share by Region (2021-2032) Figure 17. Global Hereditary Angioedema Drug Sales (2021-2032) & (W Units) Figure 18. Global Hereditary Angioedema Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 19. Global Hereditary Angioedema Drug Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Hereditary Angioedema Drug Sales YoY (2021-2032) & (W Units) Figure 21. Europe Hereditary Angioedema Drug Sales YoY (2021-2032) & (W Units) Figure 22. China Hereditary Angioedema Drug Sales YoY (2021-2032) & (W Units) Figure 23. Asia (Excluding China) Hereditary Angioedema Drug Sales YoY (2021-2032) & (W Units) Figure 24. South America, Middle East and Africa Hereditary Angioedema Drug Sales YoY (2021-2032) & (W Units) Figure 25. Global Hereditary Angioedema Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Hereditary Angioedema Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Hereditary Angioedema Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Hereditary Angioedema Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Hereditary Angioedema Drug Revenue Market Share by Type (2021-2032) Figure 31. Global Hereditary Angioedema Drug Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 32. Global Hereditary Angioedema Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Hereditary Angioedema Drug Sales Market Share by Type (2021-2032) Figure 34. Global Hereditary Angioedema Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Hereditary Angioedema Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Hereditary Angioedema Drug Revenue Market Share by Application (2021-2032) Figure 37. Global Hereditary Angioedema Drug Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 38. Global Hereditary Angioedema Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Hereditary Angioedema Drug Sales Market Share by Application (2021-2032) Figure 40. North America Hereditary Angioedema Drug Revenue Share by Type (2021-2032) Figure 41. North America Hereditary Angioedema Drug Sales Share by Type (2021-2032) Figure 42. North America Hereditary Angioedema Drug Revenue Share by Application (2021-2032) Figure 43. North America Hereditary Angioedema Drug Sales Share by Application (2021-2032) Figure 44. North America Hereditary Angioedema Drug Revenue Share by Country (2021-2032) Figure 45. North America Hereditary Angioedema Drug Sales Share by Country (2021-2032) Figure 46. Europe Hereditary Angioedema Drug Revenue Share by Type (2021-2032) Figure 47. Europe Hereditary Angioedema Drug Sales Share by Type (2021-2032) Figure 48. Europe Hereditary Angioedema Drug Revenue Share by Application (2021-2032) Figure 49. Europe Hereditary Angioedema Drug Sales Share by Application (2021-2032) Figure 50. Europe Hereditary Angioedema Drug Revenue Share by Country (2021-2032) Figure 51. Europe Hereditary Angioedema Drug Sales Share by Country (2021-2032) Figure 52. China Hereditary Angioedema Drug Revenue Share by Type (2021-2032) Figure 53. China Hereditary Angioedema Drug Sales Share by Type (2021-2032) Figure 54. China Hereditary Angioedema Drug Revenue Share by Application (2021-2032) Figure 55. China Hereditary Angioedema Drug Sales Share by Application (2021-2032) Figure 56. Asia Hereditary Angioedema Drug Revenue Share by Type (2021-2032) Figure 57. Asia Hereditary Angioedema Drug Sales Share by Type (2021-2032) Figure 58. Asia Hereditary Angioedema Drug Revenue Share by Application (2021-2032) Figure 59. Asia Hereditary Angioedema Drug Sales Share by Application (2021-2032) Figure 60. Asia Hereditary Angioedema Drug Revenue Share by Country (2021-2032) Figure 61. Asia Hereditary Angioedema Drug Sales Share by Country (2021-2032) Figure 62. SAMEA Hereditary Angioedema Drug Revenue Share by Type (2021-2032) Figure 63. SAMEA Hereditary Angioedema Drug Sales Share by Type (2021-2032) Figure 64. SAMEA Hereditary Angioedema Drug Revenue Share by Application (2021-2032) Figure 65. SAMEA Hereditary Angioedema Drug Sales Share by Application (2021-2032) Figure 66. SAMEA Hereditary Angioedema Drug Revenue Share by Country (2021-2032) Figure 67. SAMEA Hereditary Angioedema Drug Sales Share by Country (2021-2032) Figure 68. Hereditary Angioedema Drug Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Hereditary Angioedema Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • C1 Esterase Inhibitor
  • Kallikrein Inhibitor
  • Selective Bradykinin B2 Receptor Antagonist
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Takeda
  • Pharming Group NV
  • Ionis Pharmaceuticals, Inc.
  • IBio Inc.
  • CSL Limited
  • BioCryst Pharmaceuticals, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Hereditary Angioedema Drug Market by Type
  3. 1.2.1 Global Hereditary Angioedema Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 C1 Esterase Inhibitor
  5. 1.2.3 Kallikrein Inhibitor
  6. 1.2.4 Selective Bradykinin B2 Receptor Antagonist
  7. 1.3 Hereditary Angioedema Drug Market by Application
  8. 1.3.1 Global Hereditary Angioedema Drug Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital Pharmacies
  10. 1.3.3 Online Pharmacies
  11. 1.3.4 Retail Pharmacies
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Hereditary Angioedema Drug Market Dynamics
  1. 2.1 Hereditary Angioedema Drug Industry Trends
  2. 2.2 Hereditary Angioedema Drug Industry Drivers
  3. 2.3 Hereditary Angioedema Drug Industry Opportunities and Challenges
  4. 2.4 Hereditary Angioedema Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Hereditary Angioedema Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Hereditary Angioedema Drug Revenue by Region
  3. 3.2.1 Global Hereditary Angioedema Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Hereditary Angioedema Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Hereditary Angioedema Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Hereditary Angioedema Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Hereditary Angioedema Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Hereditary Angioedema Drug Sales by Region
  9. 3.4.1 Global Hereditary Angioedema Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Hereditary Angioedema Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Hereditary Angioedema Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Hereditary Angioedema Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Hereditary Angioedema Drug Revenue by Manufacturers
  2. 4.1.1 Global Hereditary Angioedema Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Hereditary Angioedema Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Hereditary Angioedema Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Hereditary Angioedema Drug Sales by Manufacturers
  6. 4.2.1 Global Hereditary Angioedema Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Hereditary Angioedema Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Hereditary Angioedema Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Hereditary Angioedema Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Hereditary Angioedema Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Hereditary Angioedema Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Hereditary Angioedema Drug Manufacturers, Product Type & Application
  13. 4.7 Global Hereditary Angioedema Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Hereditary Angioedema Drug Market CR5 and HHI
  16. 4.8.2 2025 Hereditary Angioedema Drug Tier 1, Tier 2, and Tier 3
5 Hereditary Angioedema Drug Market by Type
  1. 5.1 Global Hereditary Angioedema Drug Revenue by Type
  2. 5.1.1 Global Hereditary Angioedema Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Hereditary Angioedema Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Hereditary Angioedema Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Hereditary Angioedema Drug Sales by Type
  6. 5.2.1 Global Hereditary Angioedema Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hereditary Angioedema Drug Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Hereditary Angioedema Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Hereditary Angioedema Drug Price by Type
6 Hereditary Angioedema Drug Market by Application
  1. 6.1 Global Hereditary Angioedema Drug Revenue by Application
  2. 6.1.1 Global Hereditary Angioedema Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Hereditary Angioedema Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Hereditary Angioedema Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Hereditary Angioedema Drug Sales by Application
  6. 6.2.1 Global Hereditary Angioedema Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Hereditary Angioedema Drug Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Hereditary Angioedema Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Hereditary Angioedema Drug Price by Application
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Hereditary Angioedema Drug Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Pharming Group NV
  8. 7.2.1 Pharming Group NV Company Information
  9. 7.2.2 Pharming Group NV Business Overview
  10. 7.2.3 Pharming Group NV Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pharming Group NV Hereditary Angioedema Drug Product Portfolio
  12. 7.2.5 Pharming Group NV Recent Developments
  13. 7.3 Ionis Pharmaceuticals, Inc.
  14. 7.3.1 Ionis Pharmaceuticals, Inc. Company Information
  15. 7.3.2 Ionis Pharmaceuticals, Inc. Business Overview
  16. 7.3.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Portfolio
  18. 7.3.5 Ionis Pharmaceuticals, Inc. Recent Developments
  19. 7.4 IBio Inc.
  20. 7.4.1 IBio Inc. Company Information
  21. 7.4.2 IBio Inc. Business Overview
  22. 7.4.3 IBio Inc. Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 IBio Inc. Hereditary Angioedema Drug Product Portfolio
  24. 7.4.5 IBio Inc. Recent Developments
  25. 7.5 CSL Limited
  26. 7.5.1 CSL Limited Company Information
  27. 7.5.2 CSL Limited Business Overview
  28. 7.5.3 CSL Limited Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 CSL Limited Hereditary Angioedema Drug Product Portfolio
  30. 7.5.5 CSL Limited Recent Developments
  31. 7.6 BioCryst Pharmaceuticals, Inc.
  32. 7.6.1 BioCryst Pharmaceuticals, Inc. Company Information
  33. 7.6.2 BioCryst Pharmaceuticals, Inc. Business Overview
  34. 7.6.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Portfolio
  36. 7.6.5 BioCryst Pharmaceuticals, Inc. Recent Developments
8 North America
  1. 8.1 North America Hereditary Angioedema Drug Market Size by Type
  2. 8.1.1 North America Hereditary Angioedema Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Hereditary Angioedema Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Hereditary Angioedema Drug Price by Type (2021-2032)
  5. 8.2 North America Hereditary Angioedema Drug Market Size by Application
  6. 8.2.1 North America Hereditary Angioedema Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Hereditary Angioedema Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Hereditary Angioedema Drug Price by Application (2021-2032)
  9. 8.3 North America Hereditary Angioedema Drug Market Size by Country
  10. 8.3.1 North America Hereditary Angioedema Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Hereditary Angioedema Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Hereditary Angioedema Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Hereditary Angioedema Drug Market Size by Type
  2. 9.1.1 Europe Hereditary Angioedema Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Hereditary Angioedema Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Hereditary Angioedema Drug Price by Type (2021-2032)
  5. 9.2 Europe Hereditary Angioedema Drug Market Size by Application
  6. 9.2.1 Europe Hereditary Angioedema Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Hereditary Angioedema Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Hereditary Angioedema Drug Price by Application (2021-2032)
  9. 9.3 Europe Hereditary Angioedema Drug Market Size by Country
  10. 9.3.1 Europe Hereditary Angioedema Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Hereditary Angioedema Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Hereditary Angioedema Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Hereditary Angioedema Drug Market Size by Type
  2. 10.1.1 China Hereditary Angioedema Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Hereditary Angioedema Drug Sales by Type (2021-2032)
  4. 10.1.3 China Hereditary Angioedema Drug Price by Type (2021-2032)
  5. 10.2 China Hereditary Angioedema Drug Market Size by Application
  6. 10.2.1 China Hereditary Angioedema Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Hereditary Angioedema Drug Sales by Application (2021-2032)
  8. 10.2.3 China Hereditary Angioedema Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Hereditary Angioedema Drug Market Size by Type
  2. 11.1.1 Asia Hereditary Angioedema Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Hereditary Angioedema Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Hereditary Angioedema Drug Price by Type (2021-2032)
  5. 11.2 Asia Hereditary Angioedema Drug Market Size by Application
  6. 11.2.1 Asia Hereditary Angioedema Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Hereditary Angioedema Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Hereditary Angioedema Drug Price by Application (2021-2032)
  9. 11.3 Asia Hereditary Angioedema Drug Market Size by Country
  10. 11.3.1 Asia Hereditary Angioedema Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Hereditary Angioedema Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Hereditary Angioedema Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Hereditary Angioedema Drug Market Size by Type
  2. 12.1.1 SAMEA Hereditary Angioedema Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Hereditary Angioedema Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Hereditary Angioedema Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Hereditary Angioedema Drug Market Size by Application
  6. 12.2.1 SAMEA Hereditary Angioedema Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Hereditary Angioedema Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Hereditary Angioedema Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Hereditary Angioedema Drug Market Size by Country
  10. 12.3.1 SAMEA Hereditary Angioedema Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Hereditary Angioedema Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Hereditary Angioedema Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Hereditary Angioedema Drug Value Chain Analysis
  2. 13.1.1 Hereditary Angioedema Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Hereditary Angioedema Drug Production Mode & Process
  6. 13.2 Hereditary Angioedema Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Hereditary Angioedema Drug Distributors
  9. 13.2.3 Hereditary Angioedema Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst